TAMPA, Fla., April 24, 2024 /PRNewswire/ — Valcare Medical, Inc., a leading innovator in transcatheter-based mitral solutions, today announced a comprehensive corporate restructure aimed at accelerating the company’s plans to initiate the AMEND clinical studies following the recent company acquisition by TechWald Holding S.p.A.
As part of the restructuring, TechWald has appointed Steve Sandweg to serve as Chief Executive Officer. Sandweg brings a successful 25-year history in the medical device space having worked for both Fortune 500 and startup companies in the cardiovascular and structural heart space. Sandweg most recently served as Chief Commercial Officer for EBR Systems, Inc, developer of the world’s only wireless cardiac pacin…
Read the full article at: https://www.prnewswire.com/news-releases/valcare-medical-inc-announces-corporate-restructuring-and-appointment-of-new-ceo-302125431.html